Syndecan-1 expresszió vascularis tumorokban és epithelioid sarcomákban

Translated title of the contribution: Syndecan-1 expression in vascular tumors and epithelioid sarcomas

Orosz Zsolt, Kopper László

Research output: Contribution to journalArticle

Abstract

Purpose of study: Syndecan-1 (epithelial syndecan; a transmembrane proteoglycan) is expressed in normal squamous cells, transitional cells and plasma cells. Temporarily it appears in condensating mesenchyma during embryonal development, and in the endothelial cells of the granulation tissue in wound healing. It is present in malignant epithelial cells (depending on the grade) and hematological neoplasias. The question was how syndecan-1 is expressed in benign and malignant vascular tumors as well as in soft tissue tumors of epithelioid character. Methods: Expression of syndecan-1 was studied in 10 pyogenic granulomas and 10 Kaposi's sarcomas, and in 5 epithelioid sarcomas using monoclonal anti-syndecan-1 antibody, besides otherphenotypic markers. Results: Neither pygenic granulomas nor Kaposi's sarcomas reacted with anti-syndecan-1 antibody. However, in epithelioid sarcomas more than 90% of tumor cells showed intensive membrane positivity. Discussion: Although more and more data are available on the structure and function of syndecan-1, less is known about its appearance and rote in human malignancies, especially soft tissue sarcomas. Our results indicate that the proliferation of endothelial cells in vascular tumors or in the stroma was not accompanied by syndecan-1 expression. But it was present on the epithelioid sarcoma cells suggesting its relationship with the epithelioid phenotype.

Translated title of the contributionSyndecan-1 expression in vascular tumors and epithelioid sarcomas
Original languageHungarian
Pages (from-to)119-122
Number of pages4
JournalMagyar onkologia
Volume43
Issue number2
Publication statusPublished - Dec 1 1999

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Syndecan-1 expression in vascular tumors and epithelioid sarcomas'. Together they form a unique fingerprint.

  • Cite this